Question 1

How does Vecura leverage AI to accelerate drug discovery from natural compounds?

Accepted Answer

Vecura is an AI-driven drug discovery platform developed by Nanyang Biologics, enabling the rapid screening and analysis of millions of natural compounds. Powered by scalable AI infrastructure from partners like HPE, Vecura enhances hit quality and translational relevance, achieving 27% higher predictive accuracy and 64 times greater screening efficiency compared to traditional methods. This leads to significantly faster identification of promising therapeutic candidates while reducing R&D costs by over 50%.

Question 2

What strategic advantages does Vecura provide in advancing life sciences digital transformation?

Accepted Answer

Vecura embodies the convergence of biodiversity knowledge and AI, creating a powerful solution to map the natural compound effects on the human body accurately. Its as-a-Service platform model ensures scalability, flexibility, and security, making it ideal for organisations looking to build extensive natural drug compound libraries and accelerate innovation pipelines. This strategic edge allows life sciences companies to stay competitive by reducing timelines and enabling data-driven decision-making on a global scale.

Question 3

How does Vecura contribute to broader healthcare outcomes and research innovation?

Accepted Answer

By unlocking the therapeutic potential of natural biodiversity with advanced AI, Vecura not only speeds drug discovery but also contributes to better patient outcomes and longevity. The platform helps researchers discover treatments that may be overlooked by traditional approaches, thereby enhancing global health resilience. Vecura’s collaboration-driven ecosystem fosters innovation across sectors, reinforcing Singapore’s positioning as a biomedical and life sciences hub, with scalable AI infrastructure supporting ongoing scientific breakthroughs.

Useful Links

Our Services

Contact Us